Method of isolating regulatory T cells from human samples
View Patent ↗The present invention provides a CTLA-4 non-blocking agent of a complete human antibody nature, thus is non-immunogenic in a human. The immunoassay method using such a non-blocking agent measures the CTLA-4 content in a sample of a human subject. The present invention further provides a novel method for isolating human regulatory T cells. The resultant enriched and depleted cellular populations are useful in treating or ameliorating of human diseases.
1. A method of enriching regulatory T cells from human samples, said method comprising:
(a) contacting a population of suspended cells in a sample with a CTLA-4 non-blocking agent that recognizes the extracellular domain of CTLA-4, wherein said CTLA-4 non-blocking agent is non-immunogenic in a human and comprises an antibody or an antigen-binding fragment thereof; and
(b) selecting cells that bind to the CTLA-4 non-blocking agent, wherein the selected cells are enriched for regulatory T cells.
2. The method of claim 1 , wherein
the non-blocking agent is a human monoclonal antibody which recognizes human CTLA-4 with a Kd of about 4 nM or less.
3. The method of claim 1 , wherein
the non-blocking agent is a human IgG4λ antibody.